WENTWORTH KERRY (Chief Regulatory Officer) sold 54.3% of their position (63K shares) of NUVATION BIO INC. on the open market
Open‑market sale worth $379.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/24/2026ACC: 0001369453-26-000008
Officer· Chief Regulatory Officer
Since May 2020
-63K
Net shares
Net seller
$379.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
63K acquired · 126K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+63K
Price / share
$2.93
Trade value
$184.59K
% of position
118.9%
6/23/2026
53K→116K
Class A Common Stock
Direct
Shares
−63K
Price / share
$6.02
Trade value
$379.19K
% of position
54.3%
6/23/2026
116K→53K
Total
Net shares
+0.00
Net value
-$194.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/23/2026 | M · Option Exercise | +63K | $2.93 | $184.59K | 118.9% | 53K | 116K |
| Class A Common Stock Direct | 6/23/2026 | S · Sale | −63K | $6.02 | $379.19K | 54.3% | 116K | 53K |
| Total | +0.00 | -$194.60K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
63K shares
Shares
−63K
Strike price
2.93
Held after
152.25K
Exercisable
—
6/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock63K shares | 6/23/2026 | M · Option Exercise | −63K | 2.93 | — | 152.25K |